항암화학요법을 받는 비호지킨 림프종 환자의 증상클러스터
Symptom Clusters in Patients with Non-Hodgkin’s Lymphoma Receiving Chemotherapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to identify symptom clusters over time and examine the severity of each symptom cluster in patients with non-Hodgkin’s lymphoma receiving chemotherapy. Methods: Data were collected from 110 patients using the Memorial Symptom Assessment Scale. The data were analyzed using factor analysis. Results: Lack of energy was the most prevalent symptom on the Day 7 of chemotherapy (T1). On the day of chemotherapy of the next cycle (T2), drowsiness was the most prevalent symptom. For the timeline of T1 and T2, seven and six symptom clusters were identified, respectively. The psychological and nutrition clusters were common to both T1 and T2. The symptom scores of energy and nutrition clusters were the highest at T1, while those of the nutrition and psychological clusters were the highest at T2. Although symptom scores at T2 tended to be lower than those at T1, the symptom scores of the severe groups were still high in the nutrition, skin changes, and psychological clusters. Conclusion: Some symptom clusters can either change or appear stable over time. Furthermore, the severity of some clusters was found to be relatively high. Development of stable symptom cluster-based interventions is necessary to improve the quality of life.
Abstract
Purpose: This study aimed to identify symptom clusters over time and examine the severity of each symptom cluster in patients with non-Hodgkin’s lymphoma receiving chemotherapy. Methods: Data were collected from 110 patients using the Memorial Symptom Assessment Scale. The data were analyzed using factor analysis. Results: Lack of energy was the most prevalent symptom on the Day 7 of chemotherapy (T1). On the day of chemotherapy of the next cycle (T2), drowsiness was the most prevalent symptom. For the timeline of T1 and T2, seven and six symptom clusters were identified, respectively. The psychological and nutrition clusters were common to both T1 and T2. The symptom scores of energy and nutrition clusters were the highest at T1, while those of the nutrition and psychological clusters were the highest at T2. Although symptom scores at T2 tended to be lower than those at T1, the symptom scores of the severe groups were still high in the nutrition, skin changes, and psychological clusters. Conclusion: Some symptom clusters can either change or appear stable over time. Furthermore, the severity of some clusters was found to be relatively high. Development of stable symptom cluster-based interventions is necessary to improve the quality of life.
참고문헌 (28)
- Dodd MJ, "Symptom clusters and their effect on the functional status of patients with cancer", Oncol Nurs Forum, 28, pp.465~470 (2001)
- 김수현, "유방암 환자의 증상 클러스터", 성인간호학회지, 21(6), pp.705~717 (2009), 한국성인간호학회
- 전나미, "부인암 여성의 증상 클러스터(Symptom Cluster)", 임상간호연구, 14(1), pp.61~70 (2008), 병원간호사회
- "Annual report of cancer statistics in Korean 2019"[URL]
- Bolukbas F, "Symptoms and symptom clusters in non Hodgkin’s lymphoma patients in Turkey", Asian Pac J Cancer Prev, 15, pp.7153~7158 (2014)
- Sezgin MG, "Symptom clustering and its effect on functional status in lymphoma patients", Florence Nightingale J Nurs, 28, pp.143~154 (2020)
- Giesinger JM, "Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden", BMC Cancer, 14, pp.758~ (2014)
- Yarbro CH, "Cancer nursing: principles and practice" (2016), Jones & Bartlett Publishers
- Zelenetz AD, "NCCN guidelines insights: B-cell lymphomas, version 3.2019", J Natl Compr Canc Netw, 17, pp.650~661 (2019)
- Goodrich A, "Lymphoma therapy and adverse events : nursing strategies for thinking critically and acting decisively", Clin J Oncol Nurs, 21, pp.2~12 (2017)
- Skerman HM, "Cancer-related symptom clusters for symptom management in outpatients after commencing adjuvant chemotherapy, at 6 months, and 12 months", Support Care Cancer, 20, pp.95~105 (2012)
- 정경희, "대장암 환자 증상군의 중증도에 따른 삶의 질", Asian Oncology Nursing, 14(2), pp.74~83 (2014), 대한종양간호학회
- 조명숙, "간세포암 환자의 증상군 분류와 타당도 검증", Journal of Korean Academy of Nursing, 39(5), pp.683~692 (2009), 한국간호과학회
- 이선영, "게피티니브 치료를 받은 비소세포폐암 환자의 다발성 증상군 (Symptom Cluster)", Asian Oncology Nursing, 9(2), pp.77~85 (2009), 대한종양간호학회
- Do YS, "Symptom clusters and quality of life during sequential chemotherapy in ovarian cancer patients", pp.2015
- Lin DM, "Consensus in identification and stability of symptom clusters using different symptom dimensions in newly diagnosed acute myeloid leukemia patients undergoing induction therapy", J Pain Symptom Manage, 57, pp.783~792 (2019)
- Park BH, "Symptom cluster and quality of life in patients with hematopoietic stem cell transplantation", master, pp.2015
- Cattell RB, "The scientific use of factor analysis in behavioral and life sciences" (1978), Plenum Press
- Sapnas KG, "Minimizing sample size when using exploratory factor analysis for measurement", J Nurs Meas, 10, pp.135~154 (2002)
- Portenoy RK, "The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress", Eur J Cancer, 30A, pp.1326~1336 (1994)
- Kim SH, "Symptom clusters, performance status, and quality of life during periods of concurrent chemoradiotherapy in patients with highgrade brain cancer", pp.2015
- Lee S, "Exploratory factor analysis for a nursing workaround instrument in Korean and interpretations of statistical decision points", Comput Inform Nurs, 39, pp.329~339 (2021)
- Cherwin CH, "Distress-based gastrointestinal symptom clusters and impact on symptom interference and quality of life in patients with a hematologic malignancy receiving chemotherapy", J Pain Symptom Manage, 53, pp.751~758 (2017)
- Walsh D, "Symptom clustering in advanced cancer", Support Care Cancer, 14, pp.831~836 (2006)
- Rha SY, "Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy", Support Care Cancer, 27, pp.1687~1695 (2019)
- Papachristou N, "Network analysis of the multidimensional symptom experience of oncology", Sci Rep, 9, pp.2258~ (2019)
- Rha SY, "Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life", Support Care Cancer, 25, pp.1519~1527 (2017)
- Rha SY, "Stable symptom clusters and evolving symptom networks in relation to chemotherapy cycles", J Pain Symptom Manage, 61, pp.544~554 (2021)